LoginSignup
CSD

CS Diagnostics Corp.

Stock
Stock
Ticker: CSDX
CSDX

Price

Price

CHART BY

Frequently asked questions

The market capitalization of CS Diagnostics Corp. is $7.25M. Market capitalization is a measure of the total market value of a publicly traded company. It is calculated by multiplying the current stock price by the total number of outstanding shares.
The Price-to-Earnings (P/E) ratio (TTM) for CS Diagnostics Corp. is 96.67. This ratio helps investors assess whether a stock is overvalued or undervalued compared to its earnings.
CS Diagnostics Corp.'s Earnings Per Share (EPS) over the trailing twelve months (TTM) is 0.0004. EPS indicates the company's profitability on a per-share basis.
Over the trailing twelve months, CS Diagnostics Corp. reported a revenue of $204.00K.
CS Diagnostics Corp.'s Earnings before interest, taxes, depreciation, and amortization (EBITDA) over the trailing twelve months is $71.22K. EBITDA measures the company's overall financial performance.
CS Diagnostics Corp. has a free cash flow of $6.31K. Free cash flow indicates the cash generated after accounting for cash outflows to support operations and capital assets.
The free float of CS Diagnostics Corp. is 46.06M. Free float refers to the number of shares available for public trading, excluding restricted shares.

Financials

Market Cap 
$7.25M
EPS (TTM) 
0.0004
Free Float 
46.06M
P/E ratio (TTM) 
96.67
Revenue (TTM) 
$204.00K
EBITDA (TTM) 
$71.22K
Free Cashflow (TTM) 
$6.31K

Information

CS Diagnostics Corp. is a medical distribution company that provides advancing patient care through innovative solutions. It specializes in designing, manufacturing, and selling wellness and medical products. The company was founded by Thomas Fahrhoefer on September 25, 1996 and is headquartered in Cheyenne, WY.

Industries
Information Technology Services
Sector
Information Technology

Identifier

Primary Ticker
CSDX

Knockouts

Real-time data from LSX · Fundamentals & EOD data from FactSet
Join the conversation
Sign upLogin